Diagnostic Crossover from Obesity to Atypical Anorexia Nervosa – a Case ReportWolter H. · Schneider N. · Pfeiffer E. · Lehmkuhl U.
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité – Universitätsmedizin Berlin, Germany
Heike Wolter, MD, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité, Universitätsmedizin Berlin – Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany, Tel. +49 30/450 566 210, email@example.com
Do you have an account?
A 15-year-old, female, formerly obese adolescent was referred to our day care clinic due to self-induced massive weight loss and depressive symptoms. Intense treatment, additional dialectical behavioral therapy and psychopharmacological treatment prevented further weight loss and improved her affective state. Due to remaining anorexic symptoms such as body image distortion, outpatient psychotherapeutic treatment is continued. This case report indicates the importance of further research on diagnostic crossover from obesity to atypical anorexia nervosa.
© 2009 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.